MDxHealth is trading at $0.59, up 13.77% in pre-market on September 30, 2026; available evidence does not establish a reason for the rise. - Shares closed at $0.52 on September 29. - The company’s 2026 press-release archive lists June 29 as its latest release, and no September 30 catalyst surfaced in the search.